SCHEMBL31661772

SCHEMBL31661772

O=C(O)CCCc1ccccc1NC(=O)c1cc(I)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 10/20 0.46
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
KCNMA1 Q12791 2/20 0.41
PPARG P37231 3/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC3 O15379 1/20 0.40
EGFR P00533 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657282 1.00 SLC16A3 (0.46) SLC16A3NPC1LMNATP53GAA
SCHEMBL28134891 0.84 SLC16A3 (0.52) SLC16A3NPC1LMNAGAAHTT
SCHEMBL31661727 0.80 SLC16A3 (0.46) SLC16A3NPC1LMNATP53GAA
SCHEMBL5657531 0.80 SLC16A3 (0.46) SLC16A3NPC1LMNATP53GAA
SCHEMBL13593313 0.79 ALOX15 (0.54) HDAC1HDAC3EGFRHDAC4HDAC7
SCHEMBL31661816 0.77 SMN1; SMN2 (0.53) SLC16A3NPC1PPARG
SCHEMBL28134034 0.76 SLC16A3 (0.59) SLC16A3NPC1GAAPPARG
SCHEMBL7197436 0.74 TMPRSS4 (0.67) NPC1LMNATP53HTTKCNMA1
SCHEMBL11234468 0.73 LMNA (0.69) NPC1LMNATP53GAAHTT
SCHEMBL15943380 0.73 KCNMA1 (0.63) SLC16A3NPC1LMNATP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed